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We evaluated the epidemiologic factors of patients
seeking treatment for travel-associated illness from
January 2004 through May 2005 at the University Hospital
of Zurich. When comparing persons whose purpose of trav-
el was visiting friends and relatives (VFR travelers; n = 121)
with tourists and other travelers (n = 217), VFR travelers
showed a distinct infectious disease and risk spectrum.
VFR travelers were more likely to receive a diagnosis of
malaria (adjusted odds ratio [OR] = 2.9, 95% confidence
interval [CI] 1.2–7.3) or viral hepatitis (OR = 3.1, 95% CI
1.1–9) compared with other travelers but were less likely to
seek pretravel advice (20% vs. 67%, p = 0.0001). However,
proportionate rates of acute diarrhea were lower in VFR
(173 vs. 364 per 1,000 ill returnees). Travel to sub-Saharan
Africa contributed most to malaria in VFR travelers. In
countries with large migrant populations, improved public
health strategies are needed to reach VFR travelers.
More than 800 million tourist arrivals were registeredworldwide in 2005, and an estimated 2% of the
world’s population lives outside the country of birth (1).
Importation of infectious diseases to new countries is like-
ly to increase among both travelers and immigrants.
Approximately 80 million people from resource-rich areas
worldwide travel to resource-poor countries every year (2)
and are exposed to many infections that are no longer
prevalent in the countries where they live. Travelers visit-
ing friends and relatives (VFR travelers)—predominantly
immigrants and their children returning to their home
countries for vacations, to maintain family ties, or to visit
sick relatives—are at particularly high risk for preventable
infectious diseases, such as malaria, typhoid fever, hepati-
tis A, hepatitis B, and tuberculosis (3–5). 
A recent review of a global surveillance network’s
data set showed different demographic characteristics and
different types of travel-related illnesses among immi-
grant-VFR, traveler-VFR, and tourist travelers (5). The
population of western Europe includes ≈20 million per-
sons living in nonnative countries; most are settled immi-
grants. One third were born in a country outside of Europe
(6). In Switzerland, ≈21% (1.6 million) residents are for-
eign born (7). Compared with the health of the native pop-
ulation of Switzerland, the health status of the immigrant
population is poor (8) because of the high prevalence of
infectious diseases in the home countries (9), a difficult
psychosocial environment in the new country, inappropri-
ate risk-taking behavior (10), and social inequalities (11).
The University Hospital of Zürich serves a large pro-
portion of the city’s population, which includes a multieth-
nic range of patients and immigrants. The outpatient
departments treat ≈120,000 patients each year, and the
inpatient departments treat >35,000. We evaluated the epi-
demiology of imported infectious disease of patients seek-
ing treatment for travel-associated illness at the University
Hospital of Zürich from January 2004 through May 2005.
Patients and Methods
The University Hospital of Zürich, as part of the glob-
al GeoSentinel surveillance network, contributed clinician-
based surveillance data during a 17-month period, January
2004–June 2005, according to demographic characteris-
tics, risk for infectious disease while traveling, and fre-
quency of pretravel advice. GeoSentinel is a global
sentinel surveillance network that was established in 1995
through the International Society for Travel Medicine and
the US Centers for Disease Control and Prevention. The
network consists of 33 globally distributed member trav-
el/tropical medicine clinics (12) and has been widely used
to document travel-related illnesses (5,13–15).
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Inclusion Criteria
To be eligible, patients must have crossed an interna-
tional border ≤10 years before seeking treatment and must
have sought medical advice for a presumed travel-related
illness. Relevant travel details focused only on data from
the 6 months before the onset of illness. Only final diag-
noses were considered, and >1 diagnosis per patient was
possible. Data were collected according to a standardized,
anonymous questionnaire. The questionnaire asked for
demographic data (age, sex, country of birth, country of
residence, current citizenship), travel history during the
previous 5 years, inpatient or outpatient status, major clin-
ical symptoms (>1 per patient possible), pretravel visit
information, reason for most recent travel, and patient clas-
sification. Reasons for most recent travel were immigra-
tion, tourism, business, research/education, missionary/
volunteer work, visit to friends or relatives, and expatria-
tion. Patients were classified as immigrants/refugees, for-
eign visitors, urban expatriates, nonurban expatriates,
students, military personnel, or travelers. Working and
final diagnoses were assigned by a physician.
Definitions
An immigrant/refugee was defined as a foreign-born
person who had obtained permanent resident status or
immigrant/refugee status in Switzerland. Traveler (or tra-
ditional traveler) was defined as a resident of Switzerland
who crossed an international border and did not previous-
ly immigrate to Switzerland. When the purpose of recent
travel was visiting friends and relatives, a traveler was
termed VFR. Different patient classifications were possi-
ble (i.e., immigrant-VFR, traveler-VFR). The rate of ill-
ness was calculated as the number of patients with a
specific or a summary diagnosis as a proportion of all VFR
or traditional travelers, respectively, expressed as number
per 1,000 patients. The percentage of “chief complaints”
was expressed as the number of primary symptoms that led
to a clinic visit per total patients in each group. More than
1 chief complaint per patient was possible.
Countries were assigned to 1 of 15 regional classifica-
tions (13). Because of small case numbers, a more simpli-
fied regional classification was sometimes used:
sub-Saharan Africa, south-central America (South and
Central America), Asia (south-central, southeast, east, and
north Asia), and eastern Europe. “All other regions”
include those with no assigned travel destination. For trav-
elers or VFR who entered >1 region, the most likely place
of exposure during travel was determined to be the single
region visited.
Summary diagnosis were defined as follows: “respira-
tory tract infection” included upper and lower respiratory
infections; “malaria” infections included all malaria-caus-
ing species; “diarrhea” included acute diarrhea of parasitic,
viral, bacterial or unknown origin; “hepatitis” included
chronic or acute viral hepatitis; “viral syndrome” included
any nonspecific viral symptoms; and “AIDS/HIV/STI”
included asymptomatic HIV, acute HIV, AIDS, gonorrhea,
syphilis, and other sexually transmitted infections (STIs).
Syndrome groups such as “dermatologic disorder” were
defined as previously described (15).
Statistics
Stata software (version 9.1, Stata Corporation,
College Station, TX, USA) was used for statistical analy-
sis. Odds ratios (OR) of binary, categorical, or continuous
variables were determined by logistic regression (multi-
variate or univariate) and adjusted to age and sex if indi-
cated. Statistical significance of dichotomous variables
was achieved by using χ² or nonparametric tests.
Results
General Description and Demographic Data
We analyzed 451 patients included in the database:
181 immigrants, 227 travelers, 25 foreign visitors, and 18
others (expatriates, students, military personnel). Age
range was 16–87 years (median 33, interquartile range
27–43); 48% were female, and 20% were inpatients. The
median duration of travel was 17.5 days (interquartile
range 13–29 days). For these patients, 671 diagnoses were
counted. Leading complaints were “fever” (43.0%), “gas-
trointestinal” (42.7%), “head-ear-nose” (25.2%), “respira-
tory” (24.3%), “musculoskeletal” (12.8%), and “skin”
(11.9%, data not shown). The visits were evenly distrib-
uted during the calendar year, with no seasonal abnormi-
ties or significant associations.
Comparison of VFR and Traditional Travelers
Our analysis included 217 traditional travelers and
121 VFR travelers. For traditional travelers, the reason for
most recent travel was tourism or business. Most VFR
travelers (86%) were in the category “immigrants.” Birth
country regions of VFR travelers were Asia (30%), sub-
Saharan Africa (24%), Eastern Europe (17%), and Central
or South America (11%). The basic demographic pattern
was comparable (Table 1). VFR travelers traveled on aver-
age for a longer period than traditional travelers, were
slightly older, were more likely to have inpatient status,
and were less likely to seek pretravel advice. Traveled
regions were also comparable (Table 1). Fever and gas-
trointestinal disorders were the most frequent reasons for
seeking treatment (Table 2). Traditional travelers had more
gastrointestinal symptoms (53.91% vs. 39.66%, p = 0.03).
When the disease spectrums were compared, acute diar-
rhea was more often diagnosed in traditional travelers
(26%) than in VFR travelers (11%). The summary diagno-
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sis HIV/AIDS/STI was more commonly established in
VFR travelers (9.9% vs. 4.3%); the same was true for
malaria (7.7% vs. 2.7%). The proportionate illness patterns
are shown graphically in the online Appendix Figure
(available from www.cdc.gov/EID/content/13/2/217-
appG.htm).
When comparing VFR with traditional travelers, VFR
travelers were more likely to receive a diagnosis of malar-
ia, acute or chronic viral hepatitis, and HIV/AIDS/STI
(Table 3) but less likely to receive a diagnosis of acute
diarrhea. In contrast, traditional travelers were more likely
to receive a diagnosis of diarrhea (OR 2.1, 95% confidence
interval [CI] 1.2–3.6, p = 0.007; data not shown).
Respiratory diseases and viral syndromes were significant-
ly associated with VFR travelers only in the univariate
analysis (Table 3). Traditional travelers were significantly
more likely to seek pretravel advice compared with VFR
travelers (Table 1).
A different infectious disease spectrum and a trend
toward a distinct pattern in both VFR and traditional trav-
elers were also found when selecting different travel
regions (Figure). Malaria cases were almost exclusively
imported from the sub-Saharan Africa region; 33.3% of
diagnoses after travel to this region were attributed to
malaria in VFR travelers, compared with 12.3% in tradi-
tional travelers. In total, 27 malaria cases were recorded in
the GeoSentinel database during the 17-month period: 14
in VFR travelers, 8 in tourist travelers, 4 in recent immi-
grants, and 1 in an immigrant/refugee. Of these, 22 cases
were imported from sub-Saharan Africa and 1 from
Turkey; for 4 case-patients, no specified travel region or no
information on place of exposure was available. When
data were stratified by VFR versus traditional traveler, the
risk for malaria in sub-Saharan Africa was twice as high in
the VFR traveler group than in the traditional traveler
group (data not shown).
Discussion
The GeoSentinel site based at the University Hospital
of Zürich represents a large population in Switzerland.
However, GeoSentinel is a health facility–based surveil-
lance system and does not actively screen for certain dis-
eases. Patients included in the database do not necessarily
represent the whole population or the epidemiology or fre-
quency of the disease. Besides the unknown number of ill
returned travelers going to general practitioners or nonspe-
cialized clinics, the number of travelers returning in good
health is also unknown. Incidence rates or relative risks
therefore cannot be estimated. Similarly, patients with mild
or self-limiting disease are likely to see a general practi-
tioner rather than to go to a specialized center, although
many VFR travelers do not have a regular general practi-
tioner. On the other hand, Zürich is a large city with a
socioculturally mixed population that offers an opportuni-
ty to study immigrant-VFR travelers, and many of these
patients may prefer to go to a more anonymous university
hospital than to a general practitioner. A limitation of the
study is the relatively small number of patients included in
the database during the 17-month period, which made it
necessary to form summary diagnoses and regions.
In our analysis, VFR travelers showed a different
infectious disease and risk spectrum than did traditional
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travelers; were more likely to receive a diagnosis of malar-
ia, viral hepatitis, or HIV/AIDS/STI; and were less likely
to seek pretravel advice. Traditional travelers (mainly
tourists) were significantly more likely to seek advice
before traveling and to have a posttravel diagnosis of acute
diarrhea. This is consistent with previous studies from
European migrants returning to their home countries (16),
as well as a recent review of the global GeoSentinel data-
base (5). Malaria is most likely to be acquired in the sub-
Saharan Africa region, according to our data and those of
others (13,15). 
By contrast, acute diarrhea was the greatest problem
in traditional travelers, with an illness rate of 364 per 1,000
ill returned travelers compared with 173/1,000 in VFR
travelers. Acute diarrhea, or traveler’s diarrhea, is known
to affect >50% of travelers, depending on the destination
(17). The protective effect in VFR travelers could reflect
immunity due to recent exposure or exposure in childhood. 
Acute or chronic viral hepatitis was also significantly
associated with VFR travel, which correlates with a recent
study of hepatitis A virus infections in Swiss travelers dur-
ing a period of 12 years that identified VFR travelers as a
high-risk group, especially children of immigrants (18).
Other significant associations of disease between VFR and
traditional travelers were not found; however, this does not
necessarily mean that no such relationship exists. 
Systemic febrile illnesses, including malaria and
typhoid fever, tuberculosis, and respiratory syndromes, are
more frequently diagnosed among VFR travelers (5). In
our study, respiratory diseases contributed to the relatively
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high rate of illness in both VFR and traditional travelers
(181 vs. 184 per 1,000 ill returnees). No significant associ-
ation could be established between influenza, long trip
duration, and travel involving visiting friends and relatives
as described before (14), probably because of small num-
bers and very few cases of influenza. Viral syndrome, a
rather loosely defined summary diagnosis with unspecific
viral symptoms, was also frequently diagnosed and can be
interpreted as a flulike syndrome. Other typical tropical
infectious diseases, such as typhoid fever, leishmaniasis,
dengue fever, or brucellosis, were rarely diagnosed.
This study shows that VFR travelers are at greater risk
for certain infectious diseases and have a disease spectrum
distinct from that of traditional travelers. Malaria is the
most important, life-threatening imported disease for both
nonimmune and VFR travelers, and malaria acquisition is
even more likely in VFR travelers. For other infectious dis-
eases, HIV and STIs must also be included in the differen-
tial diagnosis, particularly for VFR travelers. VFR
travelers are vulnerable because they may visit more rural
destinations, live under poor sanitary conditions, and stay
away for longer periods (3,4). Moreover, the health condi-
tion of the immigrant population in Switzerland is poor
compared with that of the native population (8).
Prevalence gaps in disease and disparities in access to care
exist not only between countries but also between popula-
tion groups within countries. 
In addition, VFR travelers often did not seek pretrav-
el advice. Thus, culturally sensitive strategies for pretravel
contact with VFR travelers are greatly needed. Further sur-
veillance of traveler groups with denominator data is need-
ed, and prospective studies focusing on behavioral aspects
of disease prevention would allow for evidence-based
interventions as part of a public health strategy.
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